The therapy was 33 per cent effective in reducing the risk of people developing COVID-19 symptoms compared with a placebo, but that result was not statistically significant
This translation has been automatically generated and has not been verified for accuracy.AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.
Results for a subset of participants who were not infected to begin with was more encouraging but the primary analysis rested on results from all participants. The next one will likely be from a larger trial testing the product in people with a weakened immune system due to cancer or an organ transplant, who may not benefit from a vaccine.AZD7442 belongs to a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the body to fight off infections.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
British PM Boris Johnson delays plans to lift COVID-19 restrictions until July 19The British Prime Minister cited the spread of the highly transmissible Delta variant as the reason behind the move to delay lifting restrictions
Read more »
Ex-head of Myanmar's COVID-19 vaccination program arrestedThe former head of Myanmar's COVID-19 immunization program has been arrested and faces charges of high treason for colluding with opponents of the military authorities, state media reported on Monday.
Read more »
Canada donating 13M surplus COVID-19 vaccine doses to developing countriesPrime Minister Justin Trudeau pledged 13 million surplus vaccines to help the world get immunized against COVID-19 as he and other G7 leaders wrapped up a two-day summit in Britain dominated by the pandemic, climate change and China.
Read more »